153 related articles for article (PubMed ID: 8540710)
1. Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia.
Merali S; Chin K; Del Angel L; Grady RW; Armstrong M; Clarkson AB
Antimicrob Agents Chemother; 1995 Sep; 39(9):2023-6. PubMed ID: 8540710
[TBL] [Abstract][Full Text] [Related]
2. Trophozoite elimination in a rat model of Pneumocystis carinii pneumonia by clinically achievable plasma deferoxamine concentrations.
Merali S; Chin K; Grady RW; Clarkson AB
Antimicrob Agents Chemother; 1996 May; 40(5):1298-300. PubMed ID: 8723489
[TBL] [Abstract][Full Text] [Related]
3. Action of deferoxamine against Pneumocystis carinii.
Clarkson AB; Turkel-Parrella D; Williams JH; Chen LC; Gordon T; Merali S
Antimicrob Agents Chemother; 2001 Dec; 45(12):3560-5. PubMed ID: 11709340
[TBL] [Abstract][Full Text] [Related]
4. Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.
Merali S; Chin K; Grady RW; Weissberger L; Clarkson AB
Antimicrob Agents Chemother; 1995 Jul; 39(7):1442-4. PubMed ID: 7492082
[TBL] [Abstract][Full Text] [Related]
5. Clinically achievable plasma deferoxamine concentrations eliminate Pneumocystis carinii trophozoites in a rat model.
Merali S; Chin K; Grady RW; Clarkson AB
J Eukaryot Microbiol; 1996; 43(5):52S. PubMed ID: 8822854
[No Abstract] [Full Text] [Related]
6. Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia.
Clarkson AB; Sarić M; Grady RW
Antimicrob Agents Chemother; 1990 Sep; 34(9):1833-5. PubMed ID: 2285303
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
Sun P; Tong Z
Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
[TBL] [Abstract][Full Text] [Related]
8. Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia.
Hughes WT; Sillos EM; LaFon S; Rogers M; Woolley JL; Davis C; Studenberg S; Pattishall E; Freeze T; Snyder G; Staton S
J Infect Dis; 1998 Apr; 177(4):1046-56. PubMed ID: 9534981
[TBL] [Abstract][Full Text] [Related]
9. Iron chelators as therapeutic agents against Pneumocystis carinii.
Weinberg GA
Antimicrob Agents Chemother; 1994 May; 38(5):997-1003. PubMed ID: 8067783
[TBL] [Abstract][Full Text] [Related]
10. An experimental trial of artemether in treatment of Pneumocystis carinii in immunosuppressed rats.
Chen YT; Ma L; Mei Q; Tang Y; Liao XG
Chin Med J (Engl); 1994 Sep; 107(9):673-7. PubMed ID: 7805459
[TBL] [Abstract][Full Text] [Related]
11. Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia.
Walzer PD; Ashbaugh A
Antimicrob Agents Chemother; 2002 Feb; 46(2):514-6. PubMed ID: 11796365
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia.
Chin K; Merali S; Sarić M; Clarkson AB
Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effect of deferoxamine on the growth of Pneumocystis carinii in vitro.
Weinberg GA; Shaw MM
J Protozool; 1991; 38(6):223S-224S. PubMed ID: 1818180
[TBL] [Abstract][Full Text] [Related]
14. Dextran-coupled deferoxamine improves outcome in a murine model of head injury.
Panter SS; Braughler JM; Hall ED
J Neurotrauma; 1992; 9(1):47-53. PubMed ID: 1377753
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.
Porter JB; Abeysinghe RD; Marshall L; Hider RC; Singh S
Blood; 1996 Jul; 88(2):705-13. PubMed ID: 8695819
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451).
Yasuoka A; Oka S; Komuro K; Shimizu H; Kitada K; Nakamura Y; Shibahara S; Takeuchi T; Kondo S; Shimada K
Antimicrob Agents Chemother; 1995 Mar; 39(3):720-4. PubMed ID: 7793879
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat.
Liu AB; Pu Y; Zheng YQ; Cai H; Ye B
Parasite Immunol; 2014 Jul; 36(7):292-302. PubMed ID: 24702055
[TBL] [Abstract][Full Text] [Related]
19. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats.
Schmatz DM; Powles MA; McFadden DC; Pittarelli L; Balkovec J; Hammond M; Zambias R; Liberator P; Anderson J
Antimicrob Agents Chemother; 1992 Sep; 36(9):1964-70. PubMed ID: 1416888
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage.
Guo X; Qi X; Li H; Duan Z; Wei Y; Zhang F; Tian M; Ma L; You C
World Neurosurg; 2019 Aug; 128():e895-e904. PubMed ID: 31082547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
